Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. It’s just a mouse study, but intriguing all the same: Lithium may show promise as an Alzheimer’s treatment. Also, Eli Lilly’s oral weight loss pill falls short of GLP-1 stalwarts, and more. The…
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We’ve got a lot of news to get into again today, and if you want to subscribe to read all of it, STAT is running a promo right now that gives you…
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. I have a huge bag of blueberries that I picked over the weekend. If you have any recipe ideas, send them my way. Onto the biotech news today. Continue to STAT+ to…
In the latest twist over the fate of an ultra-rare disease drug, Stealth BioTherapeutics said it received “conflicting” signals from the U.S. Food and Drug Administration about information needed to approve its therapy and, consequently, is making contingency plans to close the company. At issue is a treatment for Barth syndrome, a rare illness that…
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Today we talk about the midsummer chill in the biotech market here in my home town of San Diego. Also, we learn that it was FDA cancer chief Richard Pazdur’s intervention that contributed to the…
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which…
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, and happy birthday to me! Today, we see the Senate Appropriations Committee look to increase NIH funding, despite the Trump administration’s request to slash it. Also, Trump makes drug pricing demands, and…
President Trump escalated his demands that pharma companies lower U.S. drug prices in line with what other countries pay, sending letters to 17 major drug companies Thursday that called on them to take actions by Sept. 29. He specifically asked the firms to: provide their full portfolio of drugs to Medicaid patients at prices in…
The Trump administration is proposing a voluntary program in which pharmaceutical companies can offer rebates for a small number of therapies to hospitals that participate in a federal drug discount program, an effort to sort out a controversy that has roiled the health care industry. At issue is the 340B discount program, which was created…
Today we talk about an advance in an experimental mRNA vaccine for HIV, dive deep on Vinay Prasad’s sudden FDA departure, and more. The need-to-know this morning Inside the undoing of Vinay Prasad at the FDA Vinay Prasad’s short-lived but polarizing run as head of the FDA’s biologics division ended just 84 days in, after his…